Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL

SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL

January 07, 2025

SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL

SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL

Previous: SYS6041 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL

Next: SYS6010 WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat